MoneyWorks4Me

Anthem Biosciences - Quaterly Results

13 Aug 2025 Evaluate
The turnover zoomed to Rs. 538.01 millions, up 58.92% for the June 2025 quarter as against Rs. 338.54 millions during the year-ago period.The Profit  for the quarter ended June 2025 of  Rs. 148.33  millions  grew by 73.83% from Rs. 85.33 millions.The company reported a good operating profit of 223.15 millions compared to 142.68 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202506 202406 % Var
Sales 538.01 338.54 58.92 538.01 338.54 58.92 538.01 338.54 58.92
Other Income 27.73 19.46 42.50 27.73 19.46 42.50 27.73 19.46 42.50
PBIDT 223.15 142.68 56.40 223.15 142.68 56.40 223.15 142.68 56.40
Interest 1.61 2.64 -39.02 1.61 2.64 -39.02 1.61 2.64 -39.02
PBDT 221.54 140.04 58.20 221.54 140.04 58.20 221.54 140.04 58.20
Depreciation 22.61 18.34 23.28 22.61 18.34 23.28 22.61 18.34 23.28
PBT 198.93 121.70 63.46 198.93 121.70 63.46 198.93 121.70 63.46
TAX 50.60 36.37 39.13 50.60 36.37 39.13 50.60 36.37 39.13
Deferred Tax 0.53 5.74 -90.77 0.53 5.74 -90.77 0.53 5.74 -90.77
PAT 148.33 85.33 73.83 148.33 85.33 73.83 148.33 85.33 73.83
Equity 112.32 111.82 0.45 112.32 111.82 0.45 112.32 111.82 0.45
PBIDTM(%) 41.48 42.15 -1.59 41.48 42.15 -1.59 41.48 42.15 -1.59
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..